MétaCan
Menu
← Back to cohort
Record W7117565824 · doi:10.64898/2025.12.22.25342418

Pancreatic enzymes and/or bile acids for acutely ill severely malnourished children – a double-blind randomized placebo-controlled trial

2025· article· W7117565824 on OpenAlexaff
Robert Bandsma, Mohammod Jobayer Chisti, Wieger Voskuijl, Moses Mukaba Ngari, Ezekiel Mupere, Isaiah Njagi, Johnstone Thitiri, Isabel Potani, Emmie Mbale, Dennis Chasweka, Chikondi Makwinja, Chisomo Eneya, Celine Bourdon, Abu Sadat Mohammad Sayeem Bin Shahid, Shamsun Nahar Shaima, Gazi Md. Salahuddin Mamun, Christina Lancioni, Christopher Maronga, Christopher Lwanga, Michael Atuhairwe, Kirkby D. Tickell, Caroline Tigoi, Moses Mburu, Narshion Ngao, Alex Dmitrienko, Farzana Afroze, Lubaba Shahrin, Tahmeed Ahmed, Judd L. Walson, James A. Berkley

Bibliographic record

VenuemedRxiv · 2025
Typearticle
Language
FieldNursing
TopicClinical Nutrition and Gastroenterology
Canadian institutionsHospital for Sick ChildrenUniversity of Toronto
FundersAbbott LaboratoriesBill and Melinda Gates Foundation
KeywordsIncidence (geometry)Randomized controlled trialAdverse effectMalnutritionPancreatic enzymesClinical trialPancreatic disease

Abstract

fetched live from OpenAlex

Abstract Background Translocation of bacteria across the intestinal barrier has been postulated to contribute to mortality among severely malnourished children. Pancreatic enzymes (PE) and bile acids (BA) have anti-bacterial properties in the small intestine, but severe malnutrition is associated with impaired exocrine pancreatic and hepatobiliary functions. We evaluated whether ancillary treatment with PE and BA improves survival in hospitalized, acutely ill, severely malnourished children. Methods and findings We conducted a multicenter, adaptive, 2×2 factorial, randomized, double-blinded controlled trial of PE and BA (ursodeoxycholic acid) administered for 21 days in hospitalized children with severe malnutrition. The primary outcome was mortality within 60 days of enrollment. Secondary outcomes included the incidence of Serious Adverse Events (SAEs); grade 3 or 4 toxicity events before day 21; number of days with diarrhoea; use of second- or third-line antibiotics during the admission; duration of initial hospitalization; and changes in anthropometry from enrolment to follow-up at 21 and 60 days after start of the intervention. We enrolled 429 children (median age 10.4 months (interquartile range (IQR) 4.8 18.0)). Participants were randomized to PE (n=213, 50%) or PE-placebo (n=216, 50%) and to BA (n=212, 49%) or BA-placebo (n=217, 51%). Mortality by day 60 did not differ between children assigned to PE compared to PE-placebo (36 children (17%) vs 35 (16%)), irrespective of being assigned BA or BA-placebo (Hazard ratio (HR) 1.02 (95% CI 0.64 1.62), P=0.94). Also, 39 children (18%) assigned to BA died compared to 32 (15%) with BA-placebo, irrespective of PE/PE-placebo (HR 1.27 (95%CI 0.79 2.02), P=0.32). The trial was stopped early based on futility. There were no significant differences in secondary outcomes, other than children assigned to BA spent fewer days on second-line antibiotics than those receiving BA-placebo. Conclusions Pancreatic enzymes and/or ursodeoxycholic acid do not reduce mortality, serious adverse events, or improve other clinical outcomes in hospitalized, acutely ill, severely malnourished children. Funding The Bill and Melinda Gates Foundation. Pancreatic enzymes were provided at subsidized cost by Abbott Laboratories, Illinois, Untied States and ursodeoxycholic acid was provided in kind by Opsonin Pharma Ltd., Dhaka, Bangladesh.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.007
Threshold uncertainty score0.023

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.003
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0050.002
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0030.002
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.030
GPT teacher head0.331
Teacher spread0.301 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venuemedRxiv→Same topicClinical Nutrition and Gastroenterology→French-language works237,207→